Echosens
Echosens, a pioneering company in the field of non-invasive liver diagnostics, is headquartered in France and operates across major regions including Europe, North America, and Asia. Founded in 2008, Echosens has established itself as a leader in the medical technology industry, particularly in the development of innovative solutions for liver health assessment. The company’s flagship product, FibroScan®, utilises advanced elastography technology to provide accurate measurements of liver stiffness and fat content, setting it apart from traditional biopsy methods. Echosens has achieved significant milestones, including regulatory approvals and widespread adoption in clinical settings, reinforcing its market position as a trusted provider of liver diagnostic tools. With a commitment to improving patient outcomes, Echosens continues to drive advancements in liver disease management.
DitchCarbon Score
How does Echosens's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Echosens's score of 44 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Echosens's reported carbon emissions
Echosens, headquartered in France, has set ambitious climate commitments to address its carbon emissions. Although specific emissions data for the most recent year is not available, the company has established significant reduction targets. Echosens is committed to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 46% by 2030, using 2019 as the base year. Furthermore, the company aims to achieve a remarkable 90% reduction in total GHG emissions across all scopes (Scope 1, 2, and 3) by 2050, also from a 2019 baseline. These targets have been validated through a streamlined process for small and medium-sized enterprises (SMEs) and align with the 1.5°C climate goal. Echosens is actively working to measure and reduce its Scope 3 emissions, which encompass indirect emissions in its value chain. The company's long-term commitment to achieving net-zero emissions by 2050 underscores its dedication to sustainability and climate action within the healthcare sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Echosens is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
